Director, Manufacturer & Specialty Network Partnerships Strategy

Leap

1d•$170,000 - $210,000

About The Position

Leap is a rapidly growing benefits solutions company and a pioneer in employer specialty pharmacy, focused on improving how life-changing therapies are delivered and financed. The company addresses the significant cost of specialty drugs for employers through a novel approach that eliminates hidden markups, enhances access to quality infusion providers, and promotes transparency and fairness in therapy pricing and payment. Leap partners with numerous Fortune 500 companies and leading TPAs, delivering immediate ROI through lower costs, improved access, and better patient care.

Requirements

7+ years in pharmaceutical market access, specialty pharmacy, distribution/trade, PBM, GPO, health plan, or specialty provider operations.
Hands-on ownership of pricing, chargeback, or gross-to-net analysis.
Working knowledge of ASP, WAC, GTN, 340B, buy-and-bill, chargebacks, and specialty infusion site-of-care economics.
Demonstrated ability to think in commercial models, evaluating tradeoffs across acquisition cost, manufacturer value, and employer/AIC savings.
Advanced Excel/Sheets fluency (SQL a plus).
Track record of building external-facing analytical materials (business reviews, benchmarking, value-proposition decks).
Excellent written and visual communication skills for manufacturer-, pharmacy-, and AIC-facing materials.

Nice To Haves

Experience at a specialty pharmacy, wholesaler/distributor (AmerisourceBergen, McKesson, Cardinal), infusion provider network, PBM, or integrated care company.
PharmD, MBA, or health-economics training, or equivalent pricing/analytics depth.
Familiarity with REMS programs, limited-distribution drugs, and specialty drug distribution.
Experience preparing or presenting materials for AMCP, ISPOR, or similar industry forums.
Pharma GTN (gross-to-net) experience or product-level modeling.
Skill and project work with Claude (or similar AI tools) for analytics, modeling, and content development.

Responsibilities

Build and own models to evaluate and refine GPO enrollment, WAC/direct purchasing, and distribution terms to minimize Leap's drug acquisition cost.
Translate Leap's purchasing efficiencies into clear, transparent employer savings.
Model and stress-test the impact of changes in manufacturer, pharmacy, and network mix on acquisition cost and manufacturer value, while collaborating on employer-side value.
Maintain and update gross-to-net, chargeback, and 340B leakage/impact models.
Incorporate market and competitive intelligence into Leap's model design.
Translate analytics into manufacturer-facing value propositions (e.g., ASP protection, GTN improvement, 340B impact) and pharmacy/AIC-facing savings and performance narratives.
Develop customer-ready analytics packages, including business review decks and benchmarking reports.
Maintain a library of reusable data assets and proof points for various audiences.
Serve as an analytical thought partner for manufacturer relations, specialty pharmacy/distribution, and LTN/AIC network growth.
Identify data-driven opportunities to enhance partnerships beyond price, focusing on clinical and utilization insights, and chargeback/REMS analytics.
Build business cases and supporting analysis for new LTN AIC partner onboarding and contract renewals.
Prepare acquisition-cost and value-model analysis for meetings with manufacturers, pharmacies, and AICs, and represent the analytics function in these sessions.